176th ENMC International Workshop: Diagnosis and treatment of coenzyme Q 10 deficiency

Neuromuscular Disorders

Volumn 22, Issue 1, 2012, Pages 76-86

  Rahman, Shamima ^a,b,c   Clarke, Catherine F ^d   Hirano, Michio ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UBIDECARENONE;

ADCK3 GENE; ARTICLE; CLINICAL FEATURE; COQ2 GENE; COQ6 GENE; COQ9 GENE; DISEASE MODEL; DRUG RESPONSE; ENZYME DEFICIENCY; ENZYME SYNTHESIS; ENZYME THERAPY; GENETIC ASSOCIATION; HUMAN; MUTATIONAL ANALYSIS; MUTATOR GENE; NONHUMAN; PATHOGENESIS; PDSS1 GENE; PDSS2 GENE; PRIORITY JOURNAL; SCREENING TEST; TREATMENT OUTCOME; UBIDECARENONE DEFICIENCY;

ANIMALS; HUMANS; MITOCHONDRIAL DISEASES; UBIQUINONE;

EID: 84855992976     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2011.05.001     Document Type: Article

References (64)

1. Turunen M., Olsson J., Dallner G. Metabolism and function of coenzyme Q. Biochim. Biophys. Acta 2004, 1660:171-199.
2. Kawamukai M. Biosynthesis and bioproduction of coenzyme Q10 by yeasts and other organisms. Biotechnol. Appl. Biochem. 2009, 53:217-226.
3. Bentinger M., Brismar K., Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007, 7(Suppl):S41-50.
4. Olson R.E., Rudney H. Biosynthesis of ubiquinone. Vitam. Horm. 1983, 40:1-43.
5. Tran U.C., Clarke C.F. Endogenous synthesis of coenzyme Q in eukaryotes. Mitochondrion 2007, 7(Suppl):S62-71.
6. Siebert M., Severin K., Heide L. Formation of 4-hydroxybenzoate in Escherichia coli: characterization of the ubiC gene and its encoded enzyme chorismate pyruvate-lyase. Microbiology 1994, 140(Pt 4):897-904.
7. Pierrel F., Hamelin O., Douki T., et al. Involvement of mitochondrial ferredoxin and para-aminobenzoic acid in yeast coenzyme Q biosynthesis. Chem. Biol. 2010, 17:449-459.
8. Marbois B., Xie L.X., Choi S., Hirano K., Hyman K., Clarke C.F. Para-Aminobenzoic acid is a precursor in coenzyme Q6 biosynthesis in Saccharomyces cerevisiae. J. Biol. Chem. 2010, 285:27827-27838.
9. Forsman U., Sjoberg M., Turunen M., Sindelar P.J. 4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures. Nat. Chem. Biol. 2010, 6:515-517.
10. Ogasahara S., Engel A.G., Frens D., Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:2379-2382.
11. Aure K., Benoist J.F., Ogier de Baulny H., Romero N.B., Rigal O., Lombes A. Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology 2004, 63:727-729.
12. Mollet J., Delahodde A., Serre V., et al. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am. J. Hum. Genet. 2008, 82:623-630.
13. Rötig A., Appelkvist E.L., Geromel V., et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 2000, 356:391-395.
14. Lopez L.C., Schuelke M., Quinzii C.M., et al. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet. 2006, 79:1125-1129.
15. Mollet J., Giurgea I., Schlemmer D., et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J. Clin. Invest. 2007, 117:765-772.
16. Quinzii C., Naini A., Salviati L., et al. A Mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am. J. Hum. Genet. 2006, 78:345-349.
17. Rahman S., Hargreaves I., Clayton P., Heales S. Neonatal presentation of coenzyme Q10 deficiency. J. Pediatr. 2001, 139:456-458.
18. Salviati L., Sacconi S., Murer L., et al. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 2005, 65:606-608.
19. Lamperti C., Naini A., Hirano M., et al. Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 2003, 60:1206-1208.
20. Musumeci O., Naini A., Slonim A.E., et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 2001, 56:849-855.
21. Lagier-Tourenne C., Tazir M., Lopez L.C., et al. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am. J. Hum. Genet. 2008, 82:661-672.
22. Quinzii C.M., Kattah A.G., Naini A., et al. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 2005, 64:539-541.
23. Le Ber I., Dubourg O., Benoist J.F., et al. Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1. Neurology 2007, 68:295-297.
24. Van Maldergem L., Trijbels F., DiMauro S., et al. Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann. Neurol. 2002, 52:750-754.
25. Horvath R., Schneiderat P., Schoser B.G., et al. Coenzyme Q10 deficiency and isolated myopathy. Neurology 2006, 66:253-255.
26. Lalani S.R., Vladutiu G.D., Plunkett K., Lotze T.E., Adesina A.M., Scaglia F. Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Arch. Neurol. 2005, 62:317-320.
27. Gempel K., Topaloglu H., Talim B., et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 2007, 130:2037-2044.
28. Namavar Y., Barth P.G., Kasher P.R., et al. Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia. Brain 2011, 134:143-156.
29. Duncan A.J., Heales S.J., Mills K., Eaton S., Land J.M., Hargreaves I.P. Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with di-propoxy-coenzyme Q10 as an internal standard. Clin. Chem. 2005, 51:2380-2382.
30. Duncan A.J., Bitner-Glindzicz M., Meunier B., et al. A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am. J. Hum. Genet. 2009, 84:558-566.
31. Heeringa S., Chernin G., Chak iM, et al. COQ6 mutations cause nephrotic syndrome with sensorineural deafness in humans, concurrent with increased apoptosis. J Clin Invest 2011, 121:2013-2024.
32. Diomedi-Camassei F., Di Giandomenico S., Santorelli F.M., et al. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J. Am. Soc. Nephrol. 2007, 18:2773-2780.
33. Lopez L.C., Quinzii C., Area E., et al. Treatment of CoQ10 deficient fibroblasts with ubiquinone, analogs, and vitamin C: time- and compound-dependent effects on bioenergetic and oxidative stress status. PLoS One 2010, 5:e11897.
34. Gerards M., van den Bosch B., Calis C., et al. Nonsense mutations in CABC1/ADCK3 cause progressive cerebellar ataxia and atrophy. Mitochondrion 2010, 10:510-515.
35. Bousquet I., Dujardin G., Slonimski P.P. ABC1, a novel yeast nuclear gene has a dual function in mitochondria: it suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex. EMBO J. 1991, 10:2023-2031.
36. Brasseur G., Tron G., Dujardin G., Slonimski P.P., Brivet-Chevillotte P. The nuclear ABC1 gene is essential for the correct conformation and functioning of the cytochrome bc1 complex and the neighbouring complexes II and IV in the mitochondrial respiratory chain. Eur. J. Biochem. 1997, 246:103-111.
37. Iiizumi M., Arakawa H., Mori T., Ando A., Nakamura Y. Isolation of a novel gene, CABC1, encoding a mitochondrial protein that is highly homologous to Yyast activity of bc1 complex. Cancer Res. 2002, 62:1246-1250.
38. Do T.Q., Hsu A.Y., Jonassen T., Lee P.T., Clarke C.F. A defect in coenzyme Q biosynthesis is responsible for the respiratory deficiency in Saccharomyces cerevisiae abc1 mutants. J. Biol. Chem. 2001, 276:18161-18168.
39. Hsieh E.J., Dinoso J.B., Clarke C.F. A tRNA(TRP) gene mediates the suppression of cbs2-223 previously attributed to ABC1/COQ8. Biochem. Biophys. Res. Commun. 2004, 317:648-653.
40. Tauche A., Krause-Bucholz U., Rodel G. Ubiquinone biosynthesis in Saccharomyces cerevisiae: the molecular organization of O-methylase Coq3p depends on Abc1p/Coq8p. FEMS Yeast Res. 2008, 8:1263-1275.
41. Olsen R.K., Olpin S.E., Andresen B.S., Miedzybrodzka Z.H., Pourfarzam M., Merinero B., et al. ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain 2007, 130:2045-2054.
42. Liang W.C., Ohkuma A., Hayashi Y.K., et al. ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency. Neuromuscul. Disord. 2009, 19:212-216.
43. Ohkuma A., Noguchi S., Sugie H., et al. Clinical and genetic analysis of lipid storage myopathies. Muscle Nerve 2009, 39:333-342.
44. Le Ber I., Moreira M.C., Rivaud-Pechoux S., et al. Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. Brain 2003, 126:2761-2772.
45. Matsuoka T., Maeda H., Goto Y., Nonaka I. Muscle coenzyme Q10 in mitochondrial encephalomyopathies. Neuromuscul. Disord. 1991, 1:443-447.
46. Sacconi S., Trevisson E., Salviati L., et al. Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul. Disord. 2010, 20:44-48.
47. Geromel V., Kadhom N., Ceballos-Picot I., et al. Human cultured skin fibroblasts survive profound inherited ubiquinone depletion. Free Radic. Res. 2001, 35:11-21.
48. Lopez-Martin J.M., Salviati L., Trevisson E., et al. Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis. Hum. Mol. Genet. 2007, 16:1091-1097.
49. Rodriguéz-Hernandez A., Cordero M.D., Salviati L., et al. Coenzyme Q deficiency triggers mitochondrial degradation by mitophagy. Autophagy 2009, 5:19-32.
50. Quinzii C.M., Lopez L.C., Von-Moltke J., et al. Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency. FASEB J. 2008, 22:1874-1885.
51. Quinzii C.M., Lopez L.C., Gilkerson R.W., et al. Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency. FASEB J. 2010, 24:3733-3743.
52. Ewbank J.J., Barnes T.M., Lakowski B., Lussier M., Bussey H., Hekimi S. Structural and functional conservation of the Caenorhabditis elegans timing gene clk-1. Science 1997, 275:980-983.
53. Padilla S., Jonassen T., Jimenez-Hidalgo M.A., et al. Demethoxy-Q, an intermediate of coenzyme Q biosynthesis, fails to support respiration in Saccharomyces cerevisiae and lacks antioxidant activity. J. Biol. Chem. 2004, 279:25995-26004.
54. Asencio C., Navas P., Cabello J., et al. Coenzyme Q supports distinct developmental processes in Caenorhabditis elegans. Mech. Ageing Dev. 2009, 130:145-153.
55. Lyon M.F., Hulse E.V. An inherited kidney disease of mice resembling human nephronophthisis. J. Med. Genet. 1971, 8:41-48.
56. Sibalic V., Fan X., Wuthrich R.P. Characterisation of cellular infiltration and adhesion molecule expression in CBA/CaH-kdkd mice with tubulointerstitial renal disease. Histochem. Cell Biol. 1997, 108:235-242.
57. Peng M., Jarett L., Meade R., et al. Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice. Kidney Int. 2004, 66:20-28.
58. Peng M., Falk M.J., Haase V.H., et al. PLoS Genet. 2008, 4:e1000061.
59. Saiki R., Lunceford A.L., Shi Y., et al. Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2. Am. J. Physiol. Renal. Physiol. 2008, 295:F1535-1544.
60. Bentinger M., Dallner G., Chojnacki T., Swiezewska E. Distribution and breakdown of labeled coenzyme Q10 in rat. Free Radic. Biol. Med. 2003, 34:563-575.
61. Bhagavan H.N., Chopra R.K. Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic. Res. 2006, 40:445-453.
62. Ferrante K.L., Shefner J., Zhang H., et al. Tolerance of high-dose (3000mg/day) coenzyme Q10 in ALS. Neurology 2005, 65:1834-1836.
63. Montini G., Malaventura C., Salviati L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N. Engl. J. Med. 2008, 358:2849-2850.
64. Pineda M., Montero R., Aracil A., et al. Coenzyme Q(10)-responsive ataxia: 2-year-treatment follow-up. Mov. Disord. 2010, 25:1262-1268.